Biomarker studies in northern Bohemia

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 591-597

  Binková, Blanka ^a,f   Lewtas, Joellen ^b   Míšková, Iva ^c   Rössner, Pavel ^d   Cerná, Milena ^d   Mráckové, Gabriela ^a   Peterková, Katerina ^a   Mumford, Judy ^b   Meyer, Steve ^e   Šrám, Radim ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c District Institute of Hygiene   (Czech Republic)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f Regional Institute of Hygiene   (Czech Republic)

Author keywords

Comet assay; DNA adducts; GSTM1; PAHs; Personal monitoring; Urine mutagenicity

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGE; AIR POLLUTION; BIOLOGICAL MONITORING; CHROMOSOME ABERRATION; CONFERENCE PAPER; CONTROLLED STUDY; CZECH REPUBLIC; DIET; DNA ADDUCT; DNA DAMAGE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; LYMPHOCYTE; METABOLISM; METABOLITE; MULTIVARIATE ANALYSIS; MUTAGENICITY; NORMAL HUMAN; PERSONAL MONITORING; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; URINE; WINTER;

EID: 8944247269     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3591     Document Type: Conference Paper

References (38)

1. Moldan B, Schnoor L. Czechoslovakia: restoring a critically ill environment. Environ Sci Technol 26:14-21 (1992).
2. Šrám RJ, Roznícková I, Albrecht V, Beránková A, Machovská E. Monitoring congenital anomalies in populations exposed to environmental mutagens. In: Mechanism of Environmental Mutagenesis - Carcinogenesis (Kappas A, ed). New York: Plenum Press, 1990; 255-266.
3. Šrám RJ. New ethical problems related to environmental pollution. In: Ethical Issues of Molecular Genetics in Psychiatry (Šrám RJ, Bulyzhenkov V, Prilipko L, Christen Y, eds). BerlinHeidelberg: Springer Verlag, 1991;94-105.
4. Hemminki K, Grzybowska E, Chorazy M, Twardovska-Saucha K, Sroczynski JW, Putman KL, Randerath K, Phillips DH, Hewer A, Santella RM, Young TL, Perera FP. DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis 11:1229-1231 (1990).
5. Perera FP, Hemminki K, Grzybowska E, Motykiewicz G, Michalska J, Santella RM, Young TL, Dickey C, Brandt-Rau P, DeVivo I, Blaner W, Tsai WY, Chorazy M. Molecular and genetic damage in humans from environmental pollution in Poland. Nature 360:256-258 (1992).
6. Grzybowska E, Hemminki K, Chorazy M. Seasonal variations in levels of DNA adducts and X-spots in human populations living in different parts of Poland. Environ Health Perspect 99:77-81 (1993).
7. Grzybowska E, Hemminki K, Szeliga J, Chorazy M. Seasonal variation of aromatic adducts in human lymphocytes and granulocytes. Carcinogenesis 14:2523-2526 (1993).
8. Lewtas J, Lewis C, Zweidinger R, Stevens R, Cupitt L. Sources of genotoxicity and cancer risk in ambient air. Pharmacogenetics 2:288-296 (1992).
9. Lioy PJ, Greenberg A. Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicol Ind Health 6:209-223 (1990).
10. Stevens RK, Pinto JP, Metcalfe J, Preuss P, Hartlage TA, Shoaf CR, Willis RD, Mamane Y, Novak J, Santroch J, Benes I, Lenicek J, Subert P, Bures V. Czech Air Quality Monitoring and Receptor Modeling Study. Washington:U.S. Environmental Protection Agency, 1994.
11. Lewtas J, Binková B, Míšková I, Rössner P, Cerna M, Meyer S, Mumford J, Watts R, Lenícek J, Šubrt P, Šrám RJ. Biomarkers and personal exposure to carcinogenic polycyclic aromatic hydrocarbons from air pollution. Cancer Epidemiol Biomarkers Prev (in press).
12. Cerná M, Pastorková A, Meyer S, Rössner P, Binková B, Lewtas J. The use of a urine mutagenicity assay in the monitoring of environmental exposure to genotoxins. Mutat Res (in press).
13. Binková B, Lewtas J, Míšková I, Lenícek J, Šrám R. DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. Carcinogenesis 16:1037-1046 (1995).
14. Langone JJ, Van Vunakis H. Radioimmunoassay of nicotine, cotinine and (3-pyridyl)-oxo-N-methylbutyramide. Methods Enzymol 84:628-640 (1982).
15. Williams R, Brooks L, Stevens R, Marple V, Lewtas J. Field test and laboratory evaluation of a lightweight modular designed personal sampler for human biomarker studies. In: Proceedings of the 1992 U.S. EPA/A&WMA Symposium on Measurement of Toxic and Related Air Pollutants. EPA/600/R-92/131. Washington:U.S. Environmental Protection Agency, 1992; 188-194.
16. Watts R, Lewtas J, Stevens R, Hartlage T, Pinto J, Williams R, Hattaway K, Míšková I, Benš I, Kotešovec F, Šrám R. Czech-U.S.EPA health study - assessment of personal and ambient air exposures to PAH and organic mutagens in the Teplice district of Northern Bohemia. Int J Environ Anal Chem 271-287 (1994).
17. Williams R, Mears J, Brooks L, Watts R, Lemieux P. Priority pollutant PAH analysis of incinerator emission panicles using HPLC and optimized fluorescence detection. Int J Environ Anal Chem 54:299-314 (1994).
18. 32P-postlabeling analysis of aromatic carcinogen adducts. Cancer Res 45:5656-5662 (1985).
19. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3:1081-1082 (1982).
20. Santella RM, Lin CD, Cleveland WL, Weinstein IB. Monoclonal antibodies to DNA modified by a benzo(a)pyrene diol epoxide. Carcinogenesis 5:373-377 (1984).
21. Lee BM, Santella RM. Quantitation of protein adducts as a marker of genotoxic exposure: immunologic detection of benzo(a)pyrene-globin adducts in mice. Carcinogenesis 9:1773-1777 (1988).
22. Sorsa M, Autio K, Demopoulos NA, Jarventaus H, Rössner P, Šrám RJ, Stephanou G, Vlachodimitropoulus D. Human cytogenetic biomonitoring of occupational exposure to 1,3-butadiene. Mutat Res 309:321-326 (1994).
23. Buckton KE, Evans HJ. Methods for analysis of human chromosome aberrations. Geneva:World Health Organization, 1973.
24. Perry P, Wolff S. New Giemsa method for differential staining of sister chromatids. Nature 251:156-158 (1974).
25. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191 (1988).
26. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1825 (1993).
27. Hagiwara Y, Watanabe M, Oda Y, Sofuni T, Nohmi T. Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possessing elevated levels of both nitroreductase and acetyltransferase activity. Mutat Res 291:171-180 (1993).
28. 32P-assay of DNA adducts in white blood cells and placentas of pregnant women: lack of residential wood combustion-related adducts but presence of tissue-specific endogenous adducts. Teratogenesis Carcinog Mutagen 10:373-384 (1990).
29. Gallagher JE, Everson RB, Lewtas J, George M, Lucier GW. Comparison of DNA adduct levels in human placenta from polychlorinated biphenyl exposed women and smokers in which CYP 1A1 levels are similarly elevated. Teratogenesis Carcinog Mutagen 14:183-192 (1994).
30. Hemminki K, Zhang LF, Krüger J, Autrup H, Törnquist, Norbeck HE. Exposure of bus and taxi drivers to urban air pollutants as measured by DNA and protein adducts. Toxicol Lett 72:171-174 (1994).
31. Autrup H, Vestergaard AB, Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbons-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 16:1305-1309 (1995)
32. Betti C, Davini T, Giannessi L, Loprieno N, Barale R. Comparative studies by comet test and SCE analysis in human lymphocytes from 200 healthy subjects. Mutat Res 345:201-207 (1995).
33. Perera FP, Dickey C, Santella R, Neill JOP, Albertini RJ, Ottman R, Tsai WY, Money LA, Savela K, Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis 15:2905-2910 (1994).
34. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursianen K, Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815 (1994).
35. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase Ml (GSTM1) that increases the susceptibility to bladder cancer. J Natl Cancer Inst 83:1159-1164 (1993).
36. Hirvonen A, Husgvafel-Pursianen K, Antilla S, Vanio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14:1479-1481 (1993).
37. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50:1585-1590 (1990).
38. Ichiba M, Hagmar L, Rannung A, Högstedt B, Alexandrie AK, Carstensen U, Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps. Carcinogenesis 15:1347-1352 (1994).